Neumora Therapeutics, Inc.(NMRA)
$0.43-0.01 (-1.15%)
NMRA
Neumora Therapeutics, Inc. ownership
$0.43
At close:-0.01 (-1.15%)
Want to see NMRA full AI Analyst Report?
Neumora Therapeutics, Inc. (NMRA) Ownership - Who Owns Neumora Therapeutics, Inc.?
454 Followers
Neumora Therapeutics, Inc. (NMRA) Ownership Overview
- 22.38% Insiders
- 4.69% Mutual Funds
- 20.43% Other Institutional Investors
- 6.39% ETFs
- 46.12% Public Companies and Individual Investors
The ownership structure of Neumora Therapeutics, Inc. (NMRA) stock is a mix of institutional, retail, and individual investors. Approximately 31.50% of the company’s stock is owned by Institutional Investors, 22.38% is owned by Insiders, and 46.12% is owned by Public Companies and Individual Investors.
The ownership structure of Neumora Therapeutics, Inc. (NMRA) stock is a mix of institutional, retail, and individual investors. Approximately 31.50% of the company’s stock is owned by Institutional Investors, 22.38% is owned by Insiders, and 46.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 20, 2026 | Aurora Daljit Singh | $269,179 | |
| Aug 18, 2026 | Aurora Daljit Singh | $430,180 | |
| Feb 18, 2026 | Aurora Daljit Singh | $21,886 | |
| Feb 18, 2026 | Joshua Pinto | $21,064 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Graham Capital Management, L.p. | $81,464 | |
| Jun 30, 2026 | $13,246,177 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Kristina Burow | 33,895,555 | Insider | 18.04% | 14,507,298 |
| BlackRock, Inc. | 8,140,913 | Institution | 4.33% | 3,484,311 |
| Paul Berns | 7,794,476 | Insider | 4.15% | 3,336,036 |
| Vanguard | 5,484,910 | Institution | 2.92% | 2,347,541 |
| Joseph Edelman | 5,104,097 | Institution | 2.72% | 2,184,554 |
| Ishares | 4,795,967 | Institution | 2.55% | 2,052,674 |
| Vanguard Index Funds | 4,561,614 | Institution | 2.43% | 1,952,371 |
| Fidelity Salem Street Trust | 1,228,645 | Institution | 0.65% | 525,860 |
| Fidelity Concord Street Trust | 948,933 | Institution | 0.51% | 406,143 |
| Vanguard Scottsdale Funds | 709,754 | Institution | 0.38% | 303,775 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,561,614 | Institution | 2.43% | 1,952,371 |
| Fidelity Salem Street Trust | 1,228,645 | Institution | 0.65% | 525,860 |
| Fidelity Concord Street Trust | 948,933 | Institution | 0.51% | 406,143 |
| Vanguard Scottsdale Funds | 709,754 | Institution | 0.38% | 303,775 |
| Schwab Capital Trust | 292,075 | Institution | 0.16% | 125,008 |
| Bridgeway Funds, Inc. | 225,000 | Institution | 0.12% | 96,300 |
| Vanguard World Fund | 198,483 | Institution | 0.11% | 84,951 |
| Tiaa-cref Funds | 157,413 | Institution | 0.08% | 67,373 |
| Goldman Sachs Trust | 83,427 | Institution | 0.04% | 35,707 |
| Dfa Investment Dimensions Group Inc | 79,063 | Institution | 0.04% | 33,839 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 3,435,554 | Institution | 1.83% | 2,048,277 |
| iShares Russell 2000 ETF, IWM ETF | 2,509,886 | Institution | 1.34% | 1,076,490 |
| Vanguard Extended Market ETF, VXF ETF | 1,126,060 | Institution | 0.60% | 671,357 |
| iShares Russell 2000 Growth ETF, IWO ETF | 1,066,287 | Institution | 0.57% | 457,330 |
| Vanguard Russell 2000 ETF, VTWO ETF | 602,624 | Institution | 0.32% | 359,284 |
| iShares Biotechnology ETF, IBB ETF | 587,380 | Institution | 0.31% | 251,927 |
| Schwab U.S. Small-Cap ETF, SCHA ETF | 550,315 | Institution | 0.29% | 238,286 |
| iShares Micro-Cap ETF, IWC ETF | 321,057 | Institution | 0.17% | 137,701 |
| Dimensional U.S. Small Cap ETF, DFAS ETF | 283,960 | Institution | 0.15% | 122,955 |
| EA Bridgeway Ultra-Small Company Market ETF, BUSM ETF | 217,517 | Institution | 0.12% | 102,886 |
FAQ
Who Owns Neumora Therapeutics, Inc. (NMRA)?
According to the latest TipRanks data, approximately 31.50% of the company's stock is held by institutional investors, 22.38% is held by insiders, and 46.12% is held by public companies and individual investors.
What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.50% of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors: 4.69% by mutual funds, 6.39% by ETFs and 20.43% by other institutional investors.
What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.12% of Neumora Therapeutics, Inc. (NMRA) stock is held by public companies and individual investors.
Who owns the most shares of Neumora Therapeutics, Inc. (NMRA)?
Kristina Burow owns the most shares of Neumora Therapeutics, Inc. (NMRA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

